Production of the immunosuppressive cytokine interleukin-10 by Epstein- Barr-virus-expressing pyothorax-associated lymphoma: Possible role in the development of overt lymphoma in immunocompetent hosts

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 349-357

  Kanno, Hiroyuki ^a   Naka, Norifumi ^a   Yasunaga, Yutaka ^a   Luchi, Keiji ^b   Yamauchi, Shinobu ^a   Hashimoto, Michiko ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b National Kinki Chuo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN EXPRESSION; ARTICLE; DNA DETERMINATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOPATHOLOGY; LYMPHOMA; PATHOPHYSIOLOGY; PLEURA EMPYEMA; PRIORITY JOURNAL; VIRUS EXPRESSION;

ANIMALS; BLOTTING, NORTHERN; CELL DIVISION; EMPYEMA, PLEURAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; LYMPHOMA, B-CELL; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; STAINING AND LABELING; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 0031012982     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Wolf H, Bogedain C, Schwarzmann F: Epstein-Barr virus and its interaction with the host, Intervirology 1993, 35:26-39
2. Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG: T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv 1992, 13:53-80
3. Rooney CM, Rowe M, Wallace LE, Rickinson AB: Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance. Nature 1985, 317:629-631
4. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 1987, 6:2743-2751
5. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB: Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies, J Exp Med 1992, 176:157-168
6. Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH: Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals, Transplantation 1990, 49:944-953
7. Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM: Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993, 81:2102-2109
8. Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB: Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 1991, 173:147-158
9. luchi K, Aozasa K, Yamamoto S, Mori T, Tajima K, Minato K, Mukai K, Komatsu H, Tagaki T, Kobashi Y, Yamabe H, Shimoyama M: Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax: summary of clinical and pathological findings in thirty-seven cases. Jpn J Clin Oncol 1989, 19:249-257
10. Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S: Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 1993, 143:1044-1049
11. Ohsawa M, Tomita Y, Kanno H, luchi K, Kawabata Y, Nakajima Y, Komatsu H, Mukai K, Shimoyama M, Aozasa K: Role of Epstein-Barr virus in pleural lymphomagenesis, Mod Pathol 1995, 8:848-853
12. Kanno H, Yasunaga Y, Naka N, Ohsawa M, Taniwaki M, luchi K, Torikai K, Shimoyama M, Aozasa K: Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphomas. Int J Cancer 1996, 67:86-94
13. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986, 47:883-889
14. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: lnterleukin-10. Annu Rev Immunol 1993, 11:165-190
15. Ranges GE, Figari IS, Espevik T, Palladino MA Jr: Inhibition of cytotoxic T cell development by transforming growth factor-β and reversal by recombinant tumor necrosis factor-α. J Exp Med 1987, 166:991-998
16. Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li X-F, Shimizu J, Fujiwara H, Hanaoka T: Transforming growth factor-β-induced inhibition of T cell function: susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol 1991, 146:1077-1082
17. Miyazono K, Olofsson A, Colosetti P, Heldin C-H: A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1. EMBO J 1991, 10:1091-1101
18. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin C-H, Rifkin DB: Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol 1993, 120:995-1002
19. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 1990, 248:1230-1234
20. Hsu D-H, de Waal Malefyt R, Fiorentino DF, Dang M-N, Vieira P, DeVries J, Spits H, Mosmann TR, Moore KW: Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1, Science 1990, 250:830-832
21. Kanno H, Wolfinbarger JB, Bloom ME: Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines, J Virol 1993, 67:2075-2082
22. Derynck R, Jarrett JA, Chen EY, Eaton DE, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV: Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985, 316:701-705
23. Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin C-H: TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences, Cell 1990, 61:1051-1061
24. Hudson GS, Bankier AT, Satchwell SC, Barrell BG: The short unique region of the B95-8 Epstein-Barr virus genome. Virology 1985, 147:81-98
25. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989, p 7.7
26. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992, 80:1289-1298
27. Cheung RK, Miyazaki I, Dosch H-M: Unexpected patterns of Epstein-Barr virus gene expression during early stages of B cell transformation. Int Immunol 1993, 5:707-716
28. Kanno H, Yasunaga Y, Yamauchi S, luchi K, Tatekawa T, Sugiyama H, Aozasa K: lnterleukin-6-mediated growth enhancement of cell lines derived from pyothorax-associated lymphoma. Lab Invest 1996, 75:167-173
29. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988, 48:4827-4833
30. + T lymphocytes. Int J Cancer 1995, 62:5-10
31. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu D-H, Kastelein R, Moore KW, Banchereau J: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes, Proc Natl Acad Sci USA 1992, 89:1890-1893
32. Masood R, Zhang Y, Bond MW, Scadden DT, Moudgil T, Law RE, Kaplan MH, Jung B, Espina BM, Lunardi-Iskandar Y, Levine AM, Gill PS: Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 1995, 85:3423-3430
33. Baiocchi RA, Ross ME, Tan JC, Chou C-C, Sullivan L, Haldar S, Monne M, Seiden MV, Narula SK, Sklar J, Croce CM, Caligiuri MA: Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10. Blood 1995, 85:1063-1074
34. Miyazaki I, Cheung RK, Dosch H-M: Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus, J Exp Med 1993, 178:439-447
35. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, J Exp Med 1989, 170:2081-2095
36. Burdin N, Peronne C, Banchereau J, Rousset F: Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10, J Exp Med 1993, 177:295-304
37. Baiocchi RA, Caligiuri MA: Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p, with EBV-seropositive human peripheral blood lymphocytes, Proc Natl Acad Sci USA 1994, 91:5577-5581